Alka Patel, PharmD

The FDA approved Egrifta (tesamorelin) to treat lipodystrophy in HIV-infected patients.

Somaxon Pharmaceuticals' Silenor (doxepin HCl) has been FDA approved to treat long- or short-term insomnia in patients who have difficulty maintaining sleep.

Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) was approved by the FDA for use in girls and women aged 10 to 25 for the prevention of cervical precancers and cervical cancer associated with oncogenic human papillomaviras types 16 and 18.

The FDA has approved Valturna (aliskiren/valsartan) to treat hypertension.

Trilipix has been approved by the FDA, the first and only fibrate indicated for use in combination with a statin for cholesterol management.

This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.

This novel agent for HIV patients received accelerated FDA approval.